Peptides are surging in popularity. There's little evidence that they work. FDA to weigh easing limits on unproven peptides RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for From 'Wolverine' healing claims to health warnings: The unregulated rise of peptides ABC7 Los Angeles FDA Peptide Update: Category 2 Removals Explained